Sneha Girap (Editor)

Ian Read

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Nationality  British, American
Occupation  Businessman
Name  Ian Read

Ian Read Interview Ian Read on British politicians and the Pfizer
Born  1953 (age 61–62)Forfar, Scotland
Alma mater  Imperial College London, chemical engineering (1974)
Known for  CEO, PfizerDirector, Kimberly-Clark
Salary  US$23,283,048 (total compensation, fiscal year 2014)
Education  Imperial College London (1974)
Similar People  Jeffrey B Kindler, Charles Pfizer, Kenneth C Frazier, Sally Doherty, Karl Blake

Ian C. Read (born 1953) is a Scottish-born American businessman, a chartered accountant, and since 2010 the chief executive officer (CEO) of Pfizer, the world's largest drug company.

Contents

Ian Read Pfizer39s Ian Read Confirms Commitment to UK RampD

Ian read phrma chairman of the board of directors addresses phrma14


Early life

Ian Read Pfizer Scottish boss Ian Read is dubbed the Scot39s 39lifer

Read was born in Forfar, Scotland, to a Scottish mother, but his parents returned to Rhodesia (now Zimbabwe) when he was six-weeks-old, and he grew up there.

Ian Read Sketch Pfizer prepares to coin it in Telegraph

Read received a bachelor's degree in Chemical Engineering from Imperial College London in 1974. He qualified as a chartered accountant in 1978.

Career

Ian Read Pfizer chief Ian Read to be probed by MPs over UK jobs

Read has spent his entire career with Pfizer, starting in 1978 as an operational auditor. He worked in Latin America through 1995, holding positions ranging from CFO of Pfizer Mexico (Pfizer's largest subsidiary in Latin America) to country manager of Brazil. In 1996, he was appointed president of the Pfizer International Pharmaceuticals Group, Latin America/Canada. He assumed the position of executive vice president—Europe/Canada in May 2000, added the responsibilities for Africa/Middle East region as of January 2004 and responsibilities for Latin America in March 2006. He was named vice president of Pfizer in 2001 and promoted to president of worldwide pharmaceutical operations in 2006. He is a member of the Pfizer Leadership Team.

Ian Read wwwpfizercomsitesdefaultfilesimagesabouti

On 5 December 2010, When Read "took over from Jeffrey Kindler as Pfizer’s CEO, the drug firm–the world’s largest–was facing the impending patent expiration of Lipitor, the bestselling drug ever made, and the utter failure of one of the most lavishly funded research laboratories on the planet to develop much of anything." Read is also a director of Kimberly-Clark. Read is now an American citizen.

Ian Read O39Malley Markell Express Concerns About Pfi WBAL Radio

By October 2015 during the Drug Pricing Firestorm, Forbes journalist Matthew Herper, wrote how "Read, with his calculating mind, must get through the public’s rage over six-figure price tags for breakthrough drugs and yet keep Pfizer’s pricing power more or less intact. Doing so is absolutely critical: 34% of Pfizer’s revenue growth over the past three years has come from increasing prices on existing drugs, according to SSR, a Stamford, Conn.-based consulting firm. New medicines, especially for cancer, are selling for $100,000-plus–prices that were unimaginable five years ago."

Personal life

Read has a holiday home near Bonita Springs, Florida.

References

Ian Read Wikipedia


Topics
 
B
i
Link
H2
L